Baylor Scheierman: Everything you need to know

Baylor Scheierman

#55 SG

Boston Celtics

Status

ACTIVE

STATS

Career Averages

PTS

REB

AST

BLK

STL

5.0

3.1

1.4

0.1

0.5

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	77	20	18.6	5.5	3.5	1.5	0.1	0.5	0.6	4	1.3	3.2	39.9%	0.7	1.2	60.0%	2.0	4.3	45.3%	0.4	0.4	90.3%	0.7	2.8	1.4	2.5	+199	61.6%
2024-25	31	2	12.4	3.6	2.1	1.1	0.1	0.5	0.4	0	0.8	2.6	31.7%	0.4	0.9	46.4%	1.3	3.5	35.5%	0.3	0.4	75.0%	0.6	1.5	0.7	2.8	+29	49.0%
Career	108	22	16.8	5.0	3.1	1.4	0.1	0.5	0.5	4	1.1	3.0	37.8%	0.6	1.1	56.8%	1.8	4.1	42.9%	0.3	0.4	86.0%	0.7	2.4	1.2	2.6	+228	58.5%

Career Averages

PTS

REB

AST

BLK

STL

3.5

2.2

0.4

0.1

0.5

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	7	1	14.1	4.3	2.9	0.6	0.1	0.9	0.3	1.1	3.0	38.1%	0.4	0.7	60.0%	1.6	3.7	42.3%	0.0%	1.0	1.9	1.1	2.0	-3	57.7%
2024-25	4	0	5.5	2.0	1.0	0.0	0.0	0.0	0.3	0.5	1.3	40.0%	0.3	1.3	20.0%	0.8	2.5	30.0%	0.0%	0.3	0.8	0.5	0.0	-1	40.0%
Career	11	1	11.0	3.5	2.2	0.4	0.1	0.5	0.3	0.9	2.4	38.5%	0.4	0.9	40.0%	1.3	3.3	38.9%	0.0%	0.7	1.5	0.9	1.3	-4	52.8%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/15	TOR	W 110-108	14	0	3	1	0	2	1	2	0	0.0%	1	0	0.0%	3	0	0.0%	0	0	0.0%	1	2	1.0	-9	0	2	0.0%
10/12	CLE	W 138-107	13	5	3	2	0	2	1	5	1	20.0%	0	0	0.0%	5	1	20.0%	2	2	100.0%	1	2	2.0	+8	2	6	42.5%
10/10	TOR	L 107-105	24	4	6	6	1	1	5	3	0	0.0%	6	2	33.3%	9	2	22.2%	0	0	0.0%	1	5	1.2	-1	6	2	22.2%
10/8	MEM	W 121-103	21	13	5	2	0	2	4	9	3	33.3%	4	0	0.0%	13	3	23.1%	4	4	100.0%	3	2	0.5	-3	3	8	44.0%
Preseason Totals			18.8	5.5	4.3	2.8	0.3	1.8	2.8	4.8	1.0	21.1%	2.8	0.5	18.2%	7.5	1.5	20.0%	1.5	1.5	100.0%	1.5	2.8	1.0	-5	2.8	7.3	33.7%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/9	NYK	L 112-106	30	20	4	0	0	0	0	7	6	85.7%	1	1	100.0%	8	7	87.5%	0	0	0.0%	1	3	0.0	-1	2	22	125.0%
4/7	CHA	W 113-102	9	3	2	1	0	0	0	2	1	50.0%	0	0	0.0%	2	1	50.0%	0	0	0.0%	1	1	0.0	-1	2	4	75.0%
4/5	TOR	W 115-101	16	5	5	0	0	0	0	5	1	20.0%	3	1	33.3%	8	2	25.0%	0	0	0.0%	1	4	0.0	+0	2	3	31.3%
4/3	MIL	W 133-101	22	2	2	3	0	1	1	2	0	0.0%	1	1	100.0%	3	1	33.3%	0	0	0.0%	0	2	3.0	+4	1	4	33.3%
4/1	MIA	W 147-129	17	8	2	4	0	1	1	2	2	100.0%	2	1	50.0%	4	3	75.0%	0	0	0.0%	1	1	4.0	+14	3	10	100.0%
3/30	ATL	L 112-102	25	3	2	2	0	1	1	4	1	25.0%	0	0	0.0%	4	1	25.0%	0	0	0.0%	1	1	2.0	-3	0	5	37.5%
3/29	CHA	W 114-99	28	14	1	3	0	0	2	7	3	42.9%	4	1	25.0%	11	4	36.4%	4	3	75.0%	0	1	1.5	+6	1	11	54.9%
3/27	ATL	W 109-102	28	3	6	2	0	0	1	3	1	33.3%	0	0	0.0%	3	1	33.3%	0	0	0.0%	3	3	2.0	-13	2	7	50.0%
3/25	OKC	W 119-109	19	11	5	1	0	0	0	7	3	42.9%	1	1	100.0%	8	4	50.0%	0	0	0.0%	1	4	0.0	+11	0	13	68.8%
3/22	MIN	L 102-92	28	5	4	2	0	0	0	2	1	50.0%	2	1	50.0%	4	2	50.0%	0	0	0.0%	0	4	0.0	-16	2	7	62.5%
3/20	MEM	W 117-112	23	2	4	3	0	1	0	1	0	0.0%	1	1	100.0%	2	1	50.0%	0	0	0.0%	2	2	0.0	+7	1	10	50.0%
3/18	GSW	W 120-99	24	3	8	3	0	1	1	3	1	33.3%	1	0	0.0%	4	1	25.0%	0	0	0.0%	3	5	3.0	+10	4	6	37.5%
3/16	PHX	W 120-112	25	8	5	2	0	1	0	2	2	100.0%	1	1	100.0%	3	3	100.0%	0	0	0.0%	0	5	0.0	+5	0	16	133.3%
3/14	WAS	W 111-100	24	3	9	2	0	1	1	7	1	14.3%	1	0	0.0%	8	1	12.5%	0	0	0.0%	4	5	2.0	-6	2	5	18.8%
3/12	OKC	L 104-102	33	11	7	5	0	0	1	8	3	37.5%	2	1	50.0%	10	4	40.0%	0	0	0.0%	3	4	5.0	-9	0	16	55.0%
3/10	SAS	L 125-116	35	6	6	3	0	0	2	5	2	40.0%	1	0	0.0%	6	2	33.3%	0	0	0.0%	1	5	1.5	-10	0	12	50.0%
3/8	CLE	W 109-98	25	16	10	0	0	1	0	6	4	66.7%	2	2	100.0%	8	6	75.0%	0	0	0.0%	2	8	0.0	+10	1	24	100.0%
3/6	DAL	W 120-100	20	5	2	2	0	0	0	1	1	100.0%	2	1	50.0%	3	2	66.7%	0	0	0.0%	0	2	0.0	+0	1	9	83.3%
3/4	CHA	L 118-89	31	9	4	5	0	0	3	2	1	50.0%	2	2	100.0%	4	3	75.0%	2	2	100.0%	1	3	1.7	-10	1	16	92.2%
3/2	MIL	W 108-81	24	10	6	1	0	1	1	5	2	40.0%	3	2	66.7%	8	4	50.0%	0	0	0.0%	1	5	1.0	+6	2	11	62.5%
3/1	PHI	W 114-98	31	12	4	2	1	0	1	9	2	22.2%	3	3	100.0%	12	5	41.7%	0	0	0.0%	1	3	2.0	+15	3	8	50.0%
2/27	BKN	W 148-111	22	10	3	6	0	1	0	2	2	100.0%	1	1	100.0%	3	3	100.0%	2	2	100.0%	0	3	0.0	+18	1	22	128.9%
2/25	DEN	L 103-84	24	9	4	0	0	0	1	8	3	37.5%	1	0	0.0%	9	3	33.3%	0	0	0.0%	1	3	0.0	-16	1	6	50.0%
2/24	PHX	W 97-81	31	11	11	2	0	1	2	6	1	16.7%	4	4	100.0%	10	5	50.0%	0	0	0.0%	3	8	1.0	+13	2	18	55.0%
2/22	LAL	W 111-89	28	5	2	2	0	0	0	4	1	25.0%	2	1	50.0%	6	2	33.3%	0	0	0.0%	1	1	0.0	+18	1	6	41.7%
2/19	GSW	W 121-110	24	7	5	1	0	1	2	5	1	20.0%	4	2	50.0%	9	3	33.3%	0	0	0.0%	2	3	0.5	+0	1	5	38.9%
2/11	CHI	W 124-105	23	10	5	1	0	1	0	5	2	40.0%	2	2	100.0%	7	4	57.1%	0	0	0.0%	1	4	0.0	-7	1	14	71.4%
2/8	NYK	L 111-89	29	10	13	5	0	0	1	7	2	28.6%	1	1	100.0%	8	3	37.5%	2	2	100.0%	2	11	5.0	+1	1	24	56.3%
2/6	MIA	W 98-96	18	5	7	2	1	1	0	3	1	33.3%	1	1	100.0%	4	2	50.0%	0	0	0.0%	0	7	0.0	+17	0	15	62.5%
2/4	HOU	W 114-93	23	15	10	4	0	1	2	8	3	37.5%	2	2	100.0%	10	5	50.0%	2	2	100.0%	1	9	2.0	+7	3	21	68.9%
2/3	DAL	W 110-100	28	3	7	3	1	1	0	3	1	33.3%	2	0	0.0%	5	1	20.0%	0	0	0.0%	1	6	0.0	+16	2	8	30.0%
2/1	MIL	W 107-79	13	0	4	0	0	0	0	1	0	0.0%	1	0	0.0%	2	0	0.0%	0	0	0.0%	1	3	0.0	+13	0	2	0.0%
1/30	SAC	W 112-93	30	16	5	1	0	1	0	7	4	57.1%	3	2	66.7%	10	6	60.0%	0	0	0.0%	1	4	0.0	+25	2	17	80.0%
1/28	ATL	L 117-106	16	6	3	4	0	0	0	3	0	0.0%	2	1	50.0%	5	1	20.0%	5	4	80.0%	1	2	0.0	+11	0	12	41.7%
1/26	POR	W 102-94	13	2	5	0	0	0	1	0	0	0.0%	2	1	50.0%	2	1	50.0%	0	0	0.0%	2	3	0.0	-12	3	3	50.0%
1/24	CHI	L 114-111	6	2	3	0	0	0	0	1	0	0.0%	2	1	50.0%	3	1	33.3%	0	0	0.0%	1	2	0.0	+1	1	2	33.3%
1/23	BKN	W 130-126	33	6	7	4	0	2	0	5	2	40.0%	3	0	0.0%	8	2	25.0%	0	0	0.0%	1	6	0.0	-2	0	14	37.5%
1/21	IND	W 119-104	14	5	2	1	0	1	1	2	1	50.0%	2	1	50.0%	4	2	50.0%	0	0	0.0%	0	2	1.0	-5	0	7	62.5%
1/19	DET	L 104-103	14	3	1	1	0	1	0	3	1	33.3%	0	0	0.0%	3	1	33.3%	0	0	0.0%	0	1	0.0	-3	1	3	50.0%
1/17	ATL	W 132-106	31	9	7	4	0	3	3	6	3	50.0%	1	0	0.0%	7	3	42.9%	0	0	0.0%	0	7	1.3	+2	3	12	64.3%
1/15	MIA	W 119-114	4	0	3	0	0	0	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	1	2	0.0	+0	0	3	0.0%
1/12	IND	L 98-96	20	2	3	0	0	2	0	2	0	0.0%	1	0	0.0%	3	0	0.0%	2	2	100.0%	0	3	0.0	-8	2	3	25.8%
1/10	SAS	L 100-95	26	10	2	0	0	2	1	3	2	66.7%	2	2	100.0%	5	4	80.0%	0	0	0.0%	0	2	0.0	+4	3	10	100.0%
1/7	DEN	L 114-110	4	1	1	1	0	0	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	2	1	50.0%	0	1	0.0	+13	1	2	56.8%
1/5	CHI	W 115-101	10	3	1	0	0	0	0	2	1	50.0%	0	0	0.0%	2	1	50.0%	0	0	0.0%	0	1	0.0	+5	2	1	75.0%
1/3	LAC	W 146-115	3	0	0	0	0	0	0	1	0	0.0%	0	0	0.0%	1	0	0.0%	0	0	0.0%	0	0	0.0	+4	1	1	0.0%
1/1	SAC	W 120-106	8	3	0	0	0	0	1	1	1	100.0%	0	0	0.0%	1	1	100.0%	0	0	0.0%	0	0	0.0	-2	1	2	150.0%
12/30	UTA	W 129-119	11	0	1	0	0	0	1	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	1	0.0	+2	3	3	0.0%
12/28	POR	L 114-108	7	0	0	1	0	0	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0	-4	1	3	0.0%
12/26	IND	W 140-122	20	3	5	1	0	0	0	4	1	25.0%	0	0	0.0%	4	1	25.0%	0	0	0.0%	2	3	0.0	+18	1	8	37.5%
12/22	IND	W 103-95	11	3	1	0	0	0	1	3	1	33.3%	0	0	0.0%	3	1	33.3%	0	0	0.0%	0	1	0.0	+9	0	2	50.0%
12/20	TOR	W 112-96	7	2	1	1	0	2	1	1	0	0.0%	1	1	100.0%	2	1	50.0%	0	0	0.0%	0	1	1.0	+9	4	1	50.0%
12/19	MIA	W 129-116	5	0	1	0	0	0	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	1	0.0	-10	1	2	0.0%
12/15	DET	L 112-105	14	0	0	1	0	0	0	2	0	0.0%	0	0	0.0%	2	0	0.0%	0	0	0.0%	0	0	0.0	-12	2	2	0.0%
12/11	MIL	L 116-101	8	0	0	0	0	0	0	1	0	0.0%	0	0	0.0%	1	0	0.0%	0	0	0.0%	0	0	0.0	-5	0	1	0.0%
12/7	TOR	W 121-113	6	0	1	0	0	1	0	1	0	0.0%	0	0	0.0%	1	0	0.0%	0	0	0.0%	0	1	0.0	-5	2	1	0.0%
12/5	LAL	W 126-105	15	3	1	2	0	2	1	2	1	50.0%	0	0	0.0%	2	1	50.0%	0	0	0.0%	0	1	2.0	-4	2	5	75.0%
12/4	WAS	W 146-101	25	5	6	3	0	3	1	2	1	50.0%	1	1	100.0%	3	2	66.7%	0	0	0.0%	1	5	3.0	+42	0	15	83.3%
12/2	NYK	W 123-117	2	0	0	1	0	0	0	0	0	0.0%	1	0	0.0%	1	0	0.0%	0	0	0.0%	0	0	0.0	+1	2	3	0.0%
11/30	CLE	W 117-115	15	5	2	0	0	0	2	2	1	50.0%	1	1	100.0%	3	2	66.7%	0	0	0.0%	1	1	0.0	-9	2	2	83.3%
11/29	MIN	L 119-115	13	3	0	2	0	1	1	4	1	25.0%	0	0	0.0%	4	1	25.0%	0	0	0.0%	0	0	2.0	-13	2	1	37.5%
11/26	DET	W 117-114	30	13	3	1	0	0	1	5	3	60.0%	2	2	100.0%	7	5	71.4%	0	0	0.0%	1	2	1.0	+8	6	8	92.9%
11/23	ORL	W 138-129	9	2	1	0	1	0	0	1	0	0.0%	1	1	100.0%	2	1	50.0%	0	0	0.0%	0	1	0.0	-6	1	2	50.0%
11/21	BKN	L 113-105	11	5	2	1	0	0	0	1	1	100.0%	1	1	100.0%	2	2	100.0%	0	0	0.0%	0	2	0.0	-8	1	7	125.0%
11/18	BKN	W 113-99	13	3	2	1	0	0	0	2	1	50.0%	0	0	0.0%	2	1	50.0%	0	0	0.0%	0	2	0.0	+3	2	4	75.0%
11/16	LAC	W 121-118	18	3	2	2	1	0	1	2	1	50.0%	1	0	0.0%	3	1	33.3%	0	0	0.0%	2	0	2.0	+12	1	4	50.0%
11/12	MEM	W 131-95	11	6	1	0	0	0	0	3	2	66.7%	0	0	0.0%	3	2	66.7%	0	0	0.0%	0	1	0.0	+11	1	7	100.0%
11/5	WAS	W 136-107	3	0	0	0	0	0	0	1	0	0.0%	0	0	0.0%	1	0	0.0%	0	0	0.0%	0	0	0.0	+2	1	2	0.0%
11/3	UTA	L 105-103	7	0	1	0	0	0	1	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	1	0.0	-3	1	1	0.0%
11/1	HOU	L 128-101	22	17	5	1	0	2	0	5	4	80.0%	2	2	100.0%	7	6	85.7%	1	1	100.0%	1	4	0.0	-2	1	26	114.2%
10/31	PHI	W 109-108	2	0	0	0	0	0	0	1	0	0.0%	0	0	0.0%	1	0	0.0%	0	0	0.0%	0	0	0.0	+2	1	2	0.0%
10/29	CLE	W 125-105	10	0	3	1	0	0	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	1	2	0.0	+5	1	4	0.0%
10/27	NOP	W 122-90	13	3	6	0	0	1	0	3	1	33.3%	0	0	0.0%	3	1	33.3%	0	0	0.0%	0	6	0.0	+7	0	8	50.0%
10/26	DET	L 119-113	5	0	2	0	0	0	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	1	1	0.0	-4	1	1	0.0%
10/24	NYK	L 105-95	4	0	1	0	0	0	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	1	0.0	+1	0	1	0.0%
Regular Season Totals			18.2	5.2	3.5	1.4	0.1	0.5	0.6	3.0	1.2	39.7%	1.1	0.7	61.4%	4.1	1.9	45.6%	0.3	0.3	86.4%	0.8	2.7	2.5	+179	1.4	8.7	61.3%

Postseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
5/2	PHI	L 109-100	22	0	6	2	0	1	0	3	0	0.0%	1	0	0.0%	4	0	0.0%	0	0	0.0%	2	4	0.0	-9	2	4	0.0%
4/30	PHI	L 106-93	15	5	3	1	0	2	1	3	1	33.3%	1	1	100.0%	4	2	50.0%	0	0	0.0%	0	3	1.0	+2	2	7	62.5%
4/28	PHI	L 113-97	8	3	0	0	0	0	1	2	1	50.0%	0	0	0.0%	2	1	50.0%	0	0	0.0%	0	0	0.0	-3	1	0	75.0%
4/26	PHI	W 128-96	14	6	5	0	0	0	0	5	2	40.0%	0	0	0.0%	5	2	40.0%	0	0	0.0%	2	3	0.0	+12	1	7	60.0%
4/24	PHI	W 108-100	12	6	3	1	0	2	0	4	2	50.0%	0	0	0.0%	4	2	50.0%	0	0	0.0%	2	1	0.0	-5	1	9	75.0%
4/21	PHI	L 111-97	11	5	1	0	0	1	0	1	1	100.0%	1	1	100.0%	2	2	100.0%	0	0	0.0%	1	0	0.0	-8	0	7	125.0%
4/19	PHI	W 123-91	15	5	2	0	1	0	0	3	1	33.3%	2	1	50.0%	5	2	40.0%	0	0	0.0%	0	2	0.0	+8	1	5	50.0%
Postseason Totals			14.2	4.3	2.9	0.6	0.1	0.9	0.3	3.0	1.1	38.1%	0.7	0.4	60.0%	3.7	1.6	42.3%	0.0	0.0	0.0%	1.0	1.9	2.0	-3	1.1	6.7	57.7%

Baylor Scheierman: Breaking News

Scheierman will start Saturday's Game 7 of the Eastern Conference first-round series against the 76ers, Sean Grande of NBC Sports Boston reports. The Celtics are fighting to keep their season alive with Jayson Tatum (knee) sidelined, and they'll roll with a starting lineup of Derrick White, Ron Harper, Jaylen Brown, Luka Garza and Scheierman. The second-year forward started 20 regular-season games in 2025-26, during which he averaged 9.6 points, 5.9 rebounds, 2.9 assists and 0.9 steals in 28.4 minutes per tilt.

Scheierman is not in Boston's starting lineup against Philadelphia for Game 1 of the first round of the Eastern Conference playoffs Sunday. The Celtics rested all of their starters and prominent role players in their regular-season finale against the Magic on April 12, which led to Scheierman starting and finishing with 30 points, seven assists, seven rebounds, two steals and one block over 38 minutes in a 113-108 win. The second-year pro has established a consistent role for himself off the bench this season, and he should maintain that role in the playoffs.

Scheierman recorded 30 points (8-20 FG, 6-14 3Pt, 8-8 FT), seven rebounds, seven assists, two steals and a block in 38 minutes during Sunday's 113-108 win over the Magic. Scheierman stepped into a featured role due to the Celtics benching the majority of their rotation players for the regular-season finale, and he took full advantage of the opportunity with a career-high 30 points. Unsurprisingly, Scheierman did much of his work from beyond the arc, connecting on a team-high six threes, which matched his career high. On top of his scoring, Scheierman dished out a career-high seven assists. In an expanded role over the last three games, Sheierman has averaged 19.7 points, 4.3 rebounds and 3.0 assists per game.